Table 3 Albuminuria in relation to age, sociodemographic, blood pressure and biochemical data among Type 1 and Type 2 patients
Type 1 diabetes N = (91) | Type 2 diabetes N = (153) | |||
|---|---|---|---|---|
NORMAL (N = 79) (AER ≤20 ug/min) | ABNORMAL (N = 12) (AER > 20 ug/min) | NORMAL (N = 127) (AER ≤20 ug/min) | ABNORMAL (N = 26) (AER > 20 ug/min) | |
Age at inclusion (yrs) ‡ | 20.0 (4–44.8) | 21.5 (11–38) | 51.6 (23.5–85) | 54(36.6–80) |
Duration of diabetes (yrs) ‡ | 3.0 (0–17) | 4.2 (0–9) | 3 (0–25) | 7.5(o.2–24)*** |
BMI (kg/m2) (mean ± SD) # | 19.3 ± 3.7 | 18.8 ± 4.4 | 27.9 ± 5 | 27 ± 4.7 |
SBP mmHg ‡ | 109 (72–140) | 108 (90–140) | 130(90–210) | 160 (110–200)*** |
DBP mmHg ‡ | 72 (50–110) | 80 (54–100) | 82(52–120) | 92 (70–136)*** |
AER (ug/min) ‡ | 4.9 (0.65–19.9) | 51 (22.7–290.2)*** | 4.67 (1.29–18.92) | 164.6 (22.1–2000)*** |
Creatinine clearance (mls/min) ‡ | 129(46–481) | 132(96.4–191) | 107(40–273) | 86.6(40–178.5) |
HbA1c (%) ‡ | 13.5(6.3–>14) | 14(8.9–>14) | 9.6(4.4–>14) | 10.1(5.4–>14) |
Proportion anti HT medication N(%)‡‡ | 0 | 0 | 31(24) | 15(58)** |
Proportion with Hypertension N(%)‡‡ | 7(9.7) | 2 (18.2) | 59(47.6) | 21(80.8)** |